How should gross hematuria without pain, dysuria, fever, or other urinary symptoms be evaluated and managed?

Gross Hematuria Without Symptoms: Immediate Urologic Referral Required

All adults with gross hematuria require urgent urologic evaluation with cystoscopy and imaging, regardless of whether symptoms are present or if the bleeding has resolved. This is non-negotiable given the 30-40% risk of underlying malignancy 1.

Why This Matters

Gross hematuria carries a dramatically higher cancer risk compared to microscopic hematuria. Even a single episode of visible blood in the urine—whether painless or self-limited—mandates full evaluation because:

• Malignancy risk is 30-40% in patients with gross hematuria 1
• This is 10-fold higher than microscopic hematuria (which carries only 2.6-4% cancer risk)
• Painless gross hematuria has particularly strong association with bladder and upper tract cancers 2

The Evaluation Algorithm

Step 1: Immediate Urologic Referral

Refer all patients with gross hematuria to urology without delay 2. Do not wait for the bleeding to stop or attempt to identify a "benign cause" first. The American College of Physicians explicitly states: "Clinicians should refer for further urologic evaluation in all adults with gross hematuria, even if self-limited" 2.

Step 2: Imaging - CT Urography (CTU)

CT urography with and without IV contrast is the imaging study of choice 1. This specialized protocol includes:

• Unenhanced images (to detect stones)
• Nephrographic phase (to evaluate renal parenchyma)
• Excretory phase at ≥5 minutes post-contrast (to visualize collecting system and ureters)
• Thin-slice acquisition with reconstructions

CTU has demonstrated sensitivity of 87%, specificity of 99%, and NPV of 98% for bladder malignancy in one study of 435 patients 1.

Step 3: Cystoscopy

Direct visualization of the bladder via cystoscopy is mandatory 1. This is performed by urology and cannot be replaced by imaging alone, as CTU sensitivity for bladder lesions varies (61.5-87% in different studies) 1.

Critical Pitfalls to Avoid

Don't Delay for These Reasons:

1. "The bleeding stopped" - Self-limited gross hematuria still requires full evaluation 2

2. "The patient is on anticoagulation" - Anticoagulant or antiplatelet therapy does NOT alter the need for evaluation. These medications may unmask underlying pathology but don't cause it 2, 1

3. "Let's treat the UTI first" - While infection should be treated, this doesn't eliminate the need for urologic evaluation in gross hematuria

4. "The patient is young/low risk" - Age and risk factors matter less with gross hematuria than with microscopic hematuria. The visible blood itself indicates higher risk

Don't Order These Tests:

• Urinary cytology or molecular markers - Not recommended in initial hematuria evaluation 2
• Ultrasound as primary imaging - Inadequate sensitivity (35.3% for bladder lesions) 1
• Plain radiographs (KUB) - Not appropriate for hematuria workup 1

Special Considerations

Pregnancy: If gross hematuria occurs during pregnancy, ultrasound of kidneys and bladder is appropriate initially, but full urologic evaluation including CTU or MRU and cystoscopy should be performed after delivery 1. The cancer risk doesn't disappear because of pregnancy.

Renal insufficiency: If contrast-enhanced CTU is contraindicated, MR urography without and with IV contrast is an acceptable alternative, though direct comparison data for gross hematuria is limited 1.

The Bottom Line

The evaluation pathway is straightforward and should not be modified based on symptom absence:

1. Refer to urology immediately upon identifying gross hematuria
2. CT urography (or MRU if contrast contraindicated)
3. Cystoscopy by urology
4. No exceptions for self-limited bleeding, anticoagulation, or lack of symptoms

This aggressive approach is justified because the 30-40% malignancy rate means that for every 3-4 patients you evaluate, you will detect one cancer—a detection rate that far exceeds most cancer screening programs 1.